Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chungpa-jeon is a traditional Korean herbal medicine (Hanbang) decoction developed and utilized by the Jaseng Hospital of Korean Medicine for the treatment of various musculoskeletal disorders, including intervertebral disc herniation, non-specific lower back pain, and osteoarthritis. The formulation is a complex mixture of 11 medicinal herbs: *Ostericum koreanum*, *Eucommia ulmoides*, *Acanthopanax sessiliflorus*, *Achyranthes bidentata*, *Psoralea corylifolia*, *Peucedanum japonicum*, *Cibotium barometz*, *Lycium chinense*, *Boschniakia rossica*, *Cuscuta chinensis*, and *Atractylodes japonica*. It is primarily used for its anti-inflammatory, analgesic, and bone-protective properties, which are believed to result from the synergistic effects of its phytochemical constituents. A standardized 6-herb extract derived from this formula, known as GCSB-5 (marketed as Shinbaro), has also been developed for broader pharmaceutical use. Chungpa-jeon is typically administered orally as a liquid decoction or in a dried powder form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chungpa-jeon.